Investigative Immunotherapy ImmCelz Shows Promise in Mice

Investigative Immunotherapy ImmCelz Shows Promise in Mice

295071

Investigative Immunotherapy ImmCelz Shows Promise in Mice

Creative Medical Technology Holdings has extended the applications of its investigational “regenerative immunotherapy” ImmCelz to include Parkinson’s disease, after seeing positive preclinical data from a mouse model of the disease, according to a company press release. ImmCelz inhibited the onset of Parkinson’s symptoms in a mouse model of the disease and helped protect dopamine-producing neurons — those responsible for releasing the neurotransmitter dopamine, a critical neurotransmitter that regulates brain cell activity and function – whose loss is a hallmark…

You must be logged in to read/download the full post.